MetLife Investment Management’s Crinetics Pharmaceuticals CRNX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.54M | Hold |
|
|||||
|
2025
Q1 | $1.79M | Buy |
|
|||||
|
2024
Q4 | $2.71M | Buy |
|
|||||
|
2024
Q3 | $2.3M | Hold |
|
|||||
|
2024
Q2 | $2.01M | Buy |
|
|||||
|
2024
Q1 | $1.59M | Hold |
|
|||||
|
2023
Q4 | $1.21M | Hold |
|
|||||
|
2023
Q3 | $1.01M | Buy |
|
|||||
|
2023
Q2 | $505K | Hold |
|
|||||
|
2023
Q1 | $450K | Hold |
|
|||||
|
2022
Q4 | $513K | Buy |
|
|||||
|
2022
Q3 | $535K | Buy |
|
|||||
|
2022
Q2 | $474K | Hold |
|
|||||
|
2022
Q1 | $558K | Buy |
|
|||||
|
2021
Q4 | $465K | Buy |
|
|||||
|
2021
Q3 | $245K | Hold |
|
|||||
|
2021
Q2 | $220K | Hold |
|
|||||
|
2021
Q1 | $178K | Sell |
|
|||||
|
2020
Q4 | $180K | Hold |
|
|||||
|
2020
Q3 | $200K | Hold |
|
|||||
|
2020
Q2 | $223K | Buy |
|
|||||
|
2020
Q1 | $85.8K | Hold |
|
|||||
|
2019
Q4 | $146K | Buy |
|
|||||
|
2019
Q3 | – | Sell |
|
|||||
|
2019
Q2 | $147K | Buy |
|